Loading...
Loading...
India's verapamil imports from UNITED STATES total $129.0K across 103 shipments from 15 foreign suppliers. REGIONAL PHARMACY leads with $14.3K in import value; the top 5 suppliers together control 39.2% of this origin. Leading Indian buyers include ALEMBIC PHARMACEUTICALS LIMITED. This corridor reflects India's pharmaceutical import demand for verapamil — a diversified sourcing base with multiple active suppliers from UNITED STATES.

REGIONAL PHARMACY is the leading Verapamil supplier from UNITED STATES to India, with import value of $14.3K across 5 shipments. The top 5 suppliers — REGIONAL PHARMACY, AMSTERDAM PHARMA(APTEKA RX INC), RAFF & HALL PHARMACY, KBS PHARMA, RAFF AND HALL PHARMACY — collectively account for 39.2% of total import value from this origin.
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | REGIONAL PHARMACY | $14.3K | 5 | 11.1% |
| 2 | AMSTERDAM PHARMA(APTEKA RX INC) | $10.1K | 1 | 7.8% |
| 3 | RAFF & HALL PHARMACY | $9.6K | 9 | 7.4% |
| 4 | KBS PHARMA | $9.1K | 3 | 7.0% |
| 5 | RAFF AND HALL PHARMACY | $7.5K | 6 | 5.8% |
| 6 | RAFF & HALL PHARMACY, | $7.5K | 4 | 5.8% |
| 7 | BIONPHARMA INC | $6.6K | 4 | 5.1% |
| 8 | AGRACE PHARMA | $6.1K | 2 | 4.7% |
| 9 | ESPEE BIOPHARMA & FINECHEM LLC | $5.9K | 4 | 4.5% |
| 10 | NEWLIFE MEDICALS (USA). INC. | $5.3K | 3 | 4.1% |
| 11 | NEW LIFE MEDICALS (USA),INC. | $5.1K | 2 | 4.0% |
| 12 | AMSTERDAM PHARMA (APTEKA RX INC.) | $4.4K | 1 | 3.4% |
| 13 | SPRING BIO SOLUTION | $4.3K | 8 | 3.4% |
| 14 | NEW LIFE MEDICALS (U.S.A.)INC | $4.2K | 2 | 3.3% |
| 15 | ASCENT PHARMACEUTICALS INC | $3.8K | 2 | 3.0% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | ALEMBIC PHARMACEUTICALS LIMITED | $26.4K | 11 | 20.5% |
| 2 | AJANTA PHARMA LIMITED | $18.2K | 13 | 14.1% |
| 3 | XYLOPIA LABS PRIVATE LIMITED | $16.7K | 6 | 13.0% |
| 4 | MANKIND PHARMA LIMITED | $15.7K | 9 | 12.2% |
| 5 | AZIDUS LABORATORIES LIMITED | $13.0K | 4 | 10.1% |
| 6 | ALKEM LABORATORIES LIMITED | $8.5K | 8 | 6.6% |
| 7 | NUWILL RESEARCH AND INNOVATIONS PRIVATE LIMITED | $5.4K | 5 | 4.2% |
| 8 | TORRENT PHARMACEUTICALS LTD | $5.1K | 3 | 3.9% |
| 9 | ASPHAR RESEARCH LABS PRIVATE LIMITED | $3.8K | 2 | 3.0% |
| 10 | ORBION PHARMACEUTICALS PRIVATE LIMITED | $3.3K | 2 | 2.5% |
| 11 | HIBROW HEALTHCARE PRIVATE LIMITED | $3.2K | 2 | 2.4% |
| 12 | CHEMO INDIA FORMULATION PRIVATE LIMITED | $2.4K | 2 | 1.9% |
| 13 | MICRO LABS LIMITED | $2.4K | 5 | 1.9% |
| 14 | AUROBINDO PHARMA LIMITED | $1.7K | 2 | 1.3% |
| 15 | CLIANTHA RESEARCH LIMITED | $1.5K | 4 | 1.1% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Verapamil suppliers from UNITED STATES to India include REGIONAL PHARMACY, AMSTERDAM PHARMA(APTEKA RX INC), RAFF & HALL PHARMACY. The leading supplier is REGIONAL PHARMACY with import value of $14.3K USD across 5 shipments. India imported Verapamil worth $129.0K USD from UNITED STATES in total across 103 shipments.
India imported Verapamil worth $129.0K USD from UNITED STATES across 103 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Verapamil sourced from UNITED STATES include ALEMBIC PHARMACEUTICALS LIMITED, AJANTA PHARMA LIMITED, XYLOPIA LABS PRIVATE LIMITED. The largest buyer is ALEMBIC PHARMACEUTICALS LIMITED with $26.4K in imports across 11 shipments.
The total value of Verapamil imports from UNITED STATES to India is $129.0K USD, across 103 shipments and 15 foreign suppliers. Data source: Indian Customs (DGFT).
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
103 Verified Shipments
15 suppliers, 15 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists